Chapter 18

  1. Angelos JA, Marti E, Lazary S, et al. 1991. Characterization of BPV-like DNA in equine sarcoids. Arch Virol 119:95-109.
  2. Antonsson A, Erfurt C, Hazard K, et al. 2003. Prevalence and type spectrum of human papillomaviruses in healthy skin samples collected in three continents. J Gen Virol 2003:84:1881-1886.
  3. Antonsson A, Forslund O, Ekberg H, et al. 2000. The ubiquity and impressive genomic diversity of human papillomavirus suggest a commensalic nature of the viruses. J Virol 74:11636-11641.
  4. Auborn KJ, Wang H, Vaccariello MA, et al. 1996. Kinetics of HPV11 DNA replication after infection of keratinocytes with virions. Virus Res 43:85-90.
  5. 4a. Balara JM, McCarthy RJ, Kiupel M, et al 2009. Clinical, histologic, and immunohistochemical characterization of wart-like lesions on the paw pads of dogs: 24 cases (2000-2007). J Am Vet Med Assoc 234:1555-1558.
  6. Belkin PV. 1979. Ocular lesions in canine oral papillomatosis. Vet Med Small Anim Clin 74:1520-1524.
  7. Belkin PV. 1979. Ocular lesions in canine oral papillomatosis. Virology 104:243-246.
  8. Bell JA, Sundberg JP, Ghim S, et al. 1994. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology 62:194-198.
  9. Beutner KR, Tyring S. 1997. Human papillomavirus and human disease. Am J Med 102:9-15.
  10. Bonney CH, Koch SA, Conter AW, et al. 1980. Case report: a conjunctivocorneal papilloma with evidence of a viral etiology. J Small Anim Pract 21:183-188.
  11. Bonney CH, Koch SA, Dice PF, et al. 1980. Papillomatosis of conjunctiva and adnexa in dogs. J Am Vet Med Assoc 176:48-52.
  12. Bredal WP, Thoresen SI, Rimstad E, et al. 1996. Diagnosis and clinical course of canine oral papillomavirus infection. J Small Anim Pract 37:138-142.
  13. Bregman CL, Hirth RS, Sundberg JP, et al. 1987. Cutaneous neoplasms in dogs associated with canine oral papillomavirus vaccine. Vet Pathol 24:477-487.
  14. Briggs OM. 1985. Lentiginosis profusa in the pug: three case reports. J Small Anim Pract 26:675-680.
  15. Brooks MA, Campbell L. 1992. Concurrent hypothyroidism, IgM deficiency, impaired T-cell mitogen response, and multifocal cutaneous squamous papillomas in a dog. Canine Pract 17:15-21.
  16. Calvert CA. 1990. Canine viral papillomatosis, pp 288-290. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  17. Campbell KL, Sundberg JP, Goldschmidt MH, et al. 1988. Cutaneous inverted papillomas in dogs. Vet Pathol 25:67-71
  18. Campo MS. 2002. Animal models of papillomavirus pathogenesis. Virus Res 89:249-261.
  19. Campo MS. 2003. Papillomavirus and disease in humans and animals. Vet Comp Oncol 1:3-14.
  20. Carney HC, England JJ, Hodgin EC, et al. 1990. Papillomavirus infection of aged Persian cats. J Vet Diagn Invest 2:294-299.
  21. Carpenter JL, Kreider JW, Alroy J, et al. 1992. Cutaneous xanthogranuloma and viral papilloma on a eyelid of a cat. Vet Dermatol 3:187-190.
  22. Chambers VC, Evans CA. 1959. Canine oral papillomatosis. I. Virus assay and observations on the various stages of the experimental infection. Cancer Res 19:1188-1195.
  23. Chambers VC, Evans CA, Weiser RS. 1960. Canine oral papillomatosis. II. Immunologic aspects of the disease. Cancer Res 20:1083-1093.
  24. Collier LL, Collins BK. 1994. Excision and cryosurgical ablation of severe periocular papillomatosis in a dog. J Am Vet Med Assoc 204:881-885.
  25. 23a. Croft DR, Sotir MJ, Williams CJ, et al. 2007. Occupational risks during a monkeypox outbreak, Wisconsin, 2003. Emerg Infect Dis 13:1150-1157.
  26. Davis PE, Huxtable CRR, Sabcine M. 1976. Dermal papillomas in the racing greyhound. Aust Dermatol 17:13-16.
  27. DeBay BM, Bagladi-Swanson M, Kapil S, et al. 2001. Digital papillomatosis in a confined beagle. J Vet Diagn Invest 13:346-348.
  28. Delius H, Van Ranst MA, Jenson AB, et al. 1994. Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frame. Virology 204:447-452.
  29. de Villiers EM, Fauquet C, Broker TR, et al. 2004. Classification of papillomaviruses. Virology 324:17-27.
  30. Doorbar J. 2005. The papillomavirus life cycle. J Clin Virol 32:7.
  31. 28a. Dubois ME, Slifka MK. 2008. Retrospective analysis of monkeypox infection. Emerg Infect Dis 14:592-599.
  32. Egberink HF, Berrocal A, Bax HAD, et al. 1992. Papillomavirus associated skin lesions in a cat seropositive for feline immunodeficiency virus. Vet Microbiol 31:117-125.
  33. Egberink HF, Horzinek MC. 1998. Feline viral papillomatosis, pp 113-114. In Greene CE (ed): Infectious diseases of the dog and cat, ed 2. WB Saunders, Philadelphia.
  34. Fuller TA. 1987. Fundamentals of laser surgery, pp 1-17. In Fuller TA (ed): Surgical lasers, a clinical guide. MacMillan, New York.
  35. Goldschmidt MH, Kennedy JS, Kennedy DR, et al. 2006. Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs. J Virol 80:6621-6628.
  36. Goodrich L, Gerber H, Marti E, et al. 1998. Equine sarcoids. Vet Clin North Am Equine Pract 14:607-623.
  37. Greene HS. 1953. The induction of the Shope papilloma in transplants of embryonic rabbit skin. Cancer Res 13:58-63.
  38. Gross TL, Fau-Brimacomb BH. 1986. Multifocal intraepidermal carcinoma in a dog histologically resembling Bowen's disease. Am J Dermatopathol 8:509-515.
  39. Gross TL, Ihrke PJ, Walder EJ, et al. 2005. Hyperplastic diseases of the epidermis, pp136-160. In Gross TL, Ihrke PJ, Walder EJ, et al. (eds): Skin diseases of the dog and cat. Blackwell, Oxford.
  40. Gross TL, Walder EJ. 1992. Neoplastic diseases of the skin, pp 327-484. In Gross TL, Ihrke PJ, Walder EJ (eds): Veterinary dermatology—a macroscopic and microscopic evaluation of canine and feline skin disease. Mosby, St. Louis.
  41. Gumbrell RC, Rest JR, Bredelius K, et al. 1998. Dermal fibropapillomas in cats. Vet Rec 142:376.
  42. Hanna PE, Dunn D. 2003. Cutaneous fibropapilloma in a cat (feline sarcoid). Can Vet J 44:601-602.
  43. Hare CL, Howard EB. 1977. Canine conjunctiva-corneal papillomatosis. J Am Anim Hosp Assoc 13:688-690.
  44. Harwood CA, Proby CM. 2002. Human papillomaviruses and non-melanoma skin cancer. Curr Opin Infect Dis 15:101-114.
  45. Howley PL, DR. 2003. Papillomaviruses and their replication, pp 2197-2264. In Knipe DM, Howley PM, (ed): Fields virology, ed 4. Fields, Philadelphia.
  46. Issues, Relevant law, Application of facts, and Conclusion. 1995, Papillomaviruses. In IRAC monographs on the evaluation of carcinogenic risks to humans. http://monographs.larc.fr. Accessed 5/22/11.
  47. Jarrett WF, O’Neil BW, Gaukroger JM, et al. 1990. Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec 126:473-475.
  48. Khaled H, Raafat A, Mokhtar N, et al. 2001. Human papillomavirus infection and overexpression of p53 protein in bilharzial bladder cancer. Tumori 87:256-261.
  49. Kuntsi-Vaattovaara H, Verstraete FJM, Newsome JT, et al. 2003. Resolution of persistent oral papillomatosis in a dog after treatment with a recombinant canine oral papillomavirus vaccine. Vet Comp Oncol 1:57-63.
  50. Lange C, Tobler K, Ackermann M, et al. 2009. Three novel canine papillomaviruses support taxonomic clade formation. J Gen Virol 90:2615-2621.
  51. Lange C, Tobler K, Brandes K, et al. 2010. Canine inverted papillomas are associated with DNA of four different papillomaviruses. Vet Dermatol 21:287-291.
  52. Lange CE, Tobler K, Favrot C, et al. 2009. Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay. Clin Vaccine Immunol 16:66-72.
  53. Lange CE, Tobler K, Markau T, et al. 2009. Sequence and classification of FdPV2, a papillomavirus isolated from feline Bowenoid in situ carcinomas. Vet Microbiol 137:60-65.
  54. LeClerc SM, Clark EG, Haines DM. 1997. Papillomavirus infection in association with feline cutaneous squamous cell carcinoma in situ. Proc Am Assoc Vet Derm Am Coll Vet Derm 13:125-126
  55. Le Net JL, Orth G, Sundberg JP, et al. 1997. Multiple pigmented cutaneous papules associated with a novel canine papillomavirus in an immunosuppressed dog. Vet Pathol 34:8-14.
  56. Lim PS, Jenson AB, Cowsert L, et al. 1990. Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. J Infect Dis 162:1263-1269.
  57. Lozano-Alarcon F, Lewis TP, Clark EG, et al. 1996. Persistent papillomavirus infection in a cat. J Am Anim Hosp Assoc 32:392-395.
  58. Macy DW. 2001. Cancer-causing viruses, pp 546-548. In Withrow SJ, MacEwen EG (eds): Small animal clinical oncology, ed 3. WB Saunders, Philadelphia.
  59. Matorras R, Ariteca JM, Rementeria A, et al. 1991. Human immunodeficiency virus induced immunosuppression: a risk factor for human papillomavirus infection. Am J Obstet Gynecol 164:42-44.
  60. Meunier LD. 1990. Squamous cell carcinoma in beagles subsequent to canine oral papillomavirus vaccine. Lab Anim Sci 40:568-571.
  61. M’Fadyean J, Hobday F. 1897. Note on the experimental transmission of warts in the dog. J Comp Pathol Ther 11:341-344.
  62. Moore RA, Nicholls PK, Santos EB, et al. 2002. Absence of canine oral papillomavirus DNA following prophylactic L1 particle-mediated immunotherapeutic delivery vaccination. J Gen Virol 83:2299-2301.
  63. Moore RA, Santos EB, Nicholls PK, et al. 2002. Intraepithelial DNA immunisation with a plasmid encoding a codon optimized COPY E1 gene sequence but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles. Virology 304:451-459.
  64. Moore RA, Walcott S, White KL, et al. 2003. Therapeutic immunization with COPV early genes by epithelial DNA delivery. Virology 314:630-635.
  65. 61a. Munday JS, Dunowska M, De Grey S. 2009. Detection of two different papillomaviruses within a feline cutaneous squamous cell carcinoma: Case report and review of the literature. New Zealand Vet J 57:248-251.
  66. 61b. Munday JS, French AF, MacNamara AR. 2010. The development of multiple cutaneous inverted papilloma following ovariohysterectomy in a dog. New Zealand Vet J 58:168-171.
  67. Munday JS, Howe L, French A, et al. 2009. Detection of papillomaviral DNA sequences in a feline oral squamous cell carcinoma. Res Vet Sci 86:359-361.
  68. 62a. Munday JS, Kiupel M. 2009. Papillomavirus-associated cutaneous neoplasia in mammals. Vet Pathol 47:254-264.
  69. Munday JS, Kiupel M, French AF, et al. 2008. Amplification of papillomaviral DNA sequences from a high proportion of feline cutaneous in situ and invasive squamous cell carcinomas using a nested polymerase chain reaction. Vet Dermatol 19:259-263.
  70. 63a. Munday JS, Knight CG, Howe L. 2010. The same papillomavirus is present in feline sarcoids from North America and New Zealand but not in any non-sarcoid feline samples. J Vet Diagn Invest 22:97-100.
  71. Munday JS, Willis KA, Kiupel M, et al. 2008. Amplification of three different papillomaviral DNA sequences from a cat with viral plaques. Vet Dermatol 19:400-404.
  72. 64a. Munday JS, Witham AI. 2009. Frequent detection of papillomavirus DNA in clinically normal skin of cats infected and noninfected with feline immunodeficiency virus. Veterinary Dermatology 21:307-310.
  73. Nagata M. 2000. Canine Papillomatosis, pp 569-571. In Bonagura JD (ed): Kirk's current veterinary therapy XIII. WB Saunders, Philadelphia.
  74. Nagata M, Nanko H, Moriyana A, et al. 1995. Pigmented plaques associated with papillomavirus infection in dogs. Is this epidermodysplasia verruciformis? Vet Dermatol 6:179-181.
  75. Nespeca G, Tobler K, Grest P, et al. 2006. Detection of novel papillomaviruses in paraffine-embedded samples of feline invasive and in situ squamous cell carcinoma. Am J Vet Res 67:2036-2041.
  76. Nicholls PE, Starley MA. 2000. The immunology of animal papillomaviruses. Vet Immunology Immunopath 73:101-127.
  77. Nicholls PK, Klaunberg BA, Moore RA, et al. 1999. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology 265:365-374.
  78. Nicholls PK, Stanley MA. 1999. Canine papillomavirus—a centenary review. J Comp Pathol 120:219-233.
  79. Nogueira SAF, Torres SMF, Malone ED, et al. 2006. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study. Vet Dermatol 17:259-265.
  80. Oliver R, Breuer J, Nouri A, et al. 1998. Malignancy-associated papillomaviruses: could they be factors affecting morphology of human bladder cancer? Cancer Surv 31:29-47.
  81. Orth G. 2004. Human papillomaviruses and the skin: more to be learned. J Invest Dermatol 123:XI-XIII.
  82. Rose RC, Lane C, Wilson S, et al. 1999. Oral vaccination of mice with human papillomavirus-like particles induces systemic virus-neutralizing antibodies. Vaccine 17:2129-2135.
  83. Sauder DN. 2003. Imiquimod: modes of action. Br J Dermatol 149:5-8.
  84. Schulman FY, Krafft AE, Janczewski T. 2001. Feline cutaneous fibropapillomas: clinicopathologic findings and association with papillomavirus Infection. Vet Pathol 38:291-296.
  85. Schulman FY, Krafft AE, Janczewski T, et al. 2003. Cutaneous fibropapilloma in a mountain lion (Felis concolor). J Zoo Wild Med 34:179-183.
  86. Scott DW, Miller WH, Griffin CE. 1995. A review of the cause, clinical findings, diagnosis, and clinical management of cutaneous papilloma, p 994. In Scott DW, Miller WH Jr, Griffin CE (eds): Muller and Kirk's small animal dermatology, ed 5. WB Saunders, Philadelphia.
  87. Seibel W, Sundberg JP, Lesko LJ, et al. 1989. Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles. J Invest Dermatol 93:224-230.
  88. Shimada A, Shinya K, Awakura T, et al. 1993. Cutaneous papillomatosis associated with papillomavirus infection in a dog. J Comp Pathol 108:103-107.
  89. Sironi G, Caniatti M, Scanziani E. 1990. Immunohistochemical detection of papillomavirus structural antigens in animal hyperplastic and neoplastic epithelial lesions. J Vet Med Assoc 37:760-770
  90. Stanley MA. 2002. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27:571-577.
  91. Stanley MA. 2003. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection. Expert Rev Vaccines 2:381-389.
  92. Stanley MA, Moore RA, Nicholls PK, et al. 2001. Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs. Vaccine 19:2783-2792.
  93. Sundberg JP. 1987. Papillomavirus infections in animals, pp 41-103. In Syrjanen K, Gissmann L, Koss LG (eds): Papillomaviruses and human disease. Springer, New York.
  94. Sundberg JP, Junge RE, Lancaster WD. 1984. Immunoperoxidase localization of papillomaviruses in hyperplastic and neoplastic epithelial lesions. Am J Vet Res 45:1441-1446.
  95. Sundberg JP, Montali RJ, Bush M, et al. 1994. Feline papillomaviruses: host range, molecular diversity, and epitope conservation. Vet Pathol 31:616.
  96. Sundberg JP, Montali RJ, Bush M, et al. 1996. Papillomavirus-associated focal oral hyperplasia in wild and captive Asian lions (Panthera leopersica). J Zoo Wildl Med 27:61-70.
  97. Sundberg JP, O’Bannion MK. 1989. Animal papillomaviruses associated with malignant tumors. Adv Viral Oncol 8:55-71.
  98. Sundberg JP, O’-Barion MK, Schmidt-Didier E, et al. 1986. Cloning and characterization of a canine oral papillomavirus. Am J Vet Res 47:1142-1144.
  99. Sundberg JP, Reszka AA, Williams ES, et al. 1991. An oral papillomavirus that infected one coyote and three dogs. Vet Pathol 28:87-88.
  100. Sundberg JP, Smith EK, Herron AJ, et al. 1994. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese shar pei dog. Vet Pathol 31:183-187.
  101. Sundberg JP, Van Ranst M, Montali R, et al. 2000. Feline papillomas and papillomaviruses. Vet Pathol 37:1-10.
  102. Suzich JA, Ghim SJ, Palmer-Hill FJ, et al. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92:11553-11557.
  103. Tachezy R, Duson G, Rector A, et al. 2002. Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virol 301:313-321.
  104. Tarello W. 2003. Canine granulocytic ehrlichiosis (CGE) in Italy. Acta Vet Hung 51:73-90.
  105. Teifke JP, Kidney BA, Lohr CV, et al. 2003. Detection of papillomavirus-DNA in mesenchymal tumour cells and not in the hyperplastic epithelium of feline sarcoids. Vet Derm 14:1, 47-56.
  106. Teifke JP, Löhr CV, Shirasawa H. 1998. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Vet Microbiol 60:119-130.
  107. Terai M, Burk RD. 2002. Felis domesticus papillomavirus isolated from a skin lesion is related to canine oral papillomavirus and contains a 1.3 kb non-coding region between the E2 and L2 open reading frames. J Gen Virol 83:2303-2307.
  108. Tobler K, Favrot C, Nespeca G, et al. 2006. Detection of the prototype of a potential novel genus in the family Papillomaviridae in association with canine epidermodysplasia verruciformis. J Gen Virol 87:3551-3557.
  109. Tobler K, Lange C, Carlotti DN, 2008. Detection of a novel papillomavirus in pigmented plaques of four pugs. Vet Dermatol 19:21-25.
  110. Tokita H, Konishi S. 1975. Studies on canine oral papillomatosis: II. Oncogenicity of canine oral papilloma virus to various tissues of dog with special reference to eye tumor. Jpn J Vet Sci 37:10-120.
  111. Watrach AM, Small E, Case MT. 1970. Canine papillomas: progression of oral papilloma to carcinoma. J Natl Cancer Inst 45:915-920.
  112. White SD. 1996. Newly introduced drugs in veterinary dermatology, p 84. In ECVD/ACVD (ed): World Congress of Veterinary Dermatology, Edinburgh, Scotland.
  113. Wilhelm S, Degorce-Rubiales F, Godson D, et al. 2006. Clinical, histological and immunohistochemical study of feline viral plaques and Bowenoid in situ carcinomas. Vet Dermatol 17:424-431.
  114. 105a. Yagˇci BB, Ural K, Ocal N, et al. 2008. Azithromycin therapy of papillomatosis in dogs: a prospective, randomized, double-blinded, placebo-controlled clinical trial. Vet Dermatol 19:194-198.
  115. 105b. Yhee JY, Kwon BJ, Kim JH, et al. 2010. Characterization of canine oral papillomavirus by histopathological and genetic analysis in Korea. J Vet Sci 11:21-25.
  116. Yuan H, Ghim S, Newsome J, et al. 2007. An epidermotropic canine papillomavirus with malignant potential contains an E5 gene and establishes a unique genus. Virology 359:28-36.
  117. Zaugg N, Nespeca G, Hauser B, et al. 2005. Detection of novel papillomaviruses in canine mucosal, cutaneous and in situ squamous cell carcinomas. Vet Dermatol 16:290-298.
  118. Zur Hausen H. 1996. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1288:55-78.
  119. Zur Hausen H. 2001. Oncogenic DNA viruses. Oncogene 20:7820-7823.